Rituximab Treatment for Polyneuropathy Induced by an Immune Checkpoint Inhibitor
Journal of the Korean Neurological Association
;
: 329-332, 2018.
Artículo
en Coreano
| WPRIM
| ID: wpr-766719
ABSTRACT
Immune checkpoint inhibitor is associated with variety of immune-related adverse events. We present a case of polyneuropathy induced by immune checkpoint inhibitor, which was refractory to steroid and immunoglobulin. While high-dose steroid and immunoglobulin were not effective, we tried rituximab which is effective in other immune-mediated polyneuropathy. After rituximab treatment, patient's clinical symptom and nerve conduction study finding was markedly improved. We suggest rituximab might be effective in polyneuropathy induced by immune checkpoint inhibitor.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Polineuropatías
/
Enfermedades Autoinmunes
/
Inmunoglobulinas
/
Rituximab
/
Conducción Nerviosa
Idioma:
Coreano
Revista:
Journal of the Korean Neurological Association
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS